Incidence of new-onset diabetes among sudanese renal transplant patients using different immunosuppressive regimens: A retrospective study

Background: New onset diabetes after renal transplant (NODAT) is a serious complication of therapy with immunosuppressive drugs. The aim of this study was to estimate the incidence of NODAT and its association with immunosuppressant regimens within 6 months of the administration. Methodology: A desc...

Full description

Bibliographic Details
Main Authors: Alaa Mohammedazeem Elzain, Safaa Badi, Bashir Alsiddig Yousef, Habab Khalid Elkheir
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:CHRISMED Journal of Health and Research
Subjects:
Online Access:http://www.cjhr.org/article.asp?issn=2348-3334;year=2021;volume=8;issue=2;spage=110;epage=116;aulast=Elzain
_version_ 1818567689955704832
author Alaa Mohammedazeem Elzain
Safaa Badi
Bashir Alsiddig Yousef
Habab Khalid Elkheir
author_facet Alaa Mohammedazeem Elzain
Safaa Badi
Bashir Alsiddig Yousef
Habab Khalid Elkheir
author_sort Alaa Mohammedazeem Elzain
collection DOAJ
description Background: New onset diabetes after renal transplant (NODAT) is a serious complication of therapy with immunosuppressive drugs. The aim of this study was to estimate the incidence of NODAT and its association with immunosuppressant regimens within 6 months of the administration. Methodology: A descriptive retrospective case finding hospital-based study, conducted in the department of nephrology at Ahmed Gasim Hospital from January to September 2017, on patients who underwent renal transplantation between June 2015 and June 2016. The data were collected using a structured checklist. The collected data were analyzed by the Statistical Package for Social Sciences (SPSS). Results: A total of 110 patients were included, the majority of studied patients were males (71.8%) and in the age group of 20–40 years (50.9%). The most commonly prescribed immunosuppressant regimen was regimen, which consists of methylprednisolone as induction therapy and tacrolimus + azathioprine + prednisolone as maintenance therapy. Regarding the adverse effects, 11 (10%) of them developed NODAT throughout 6 months after transplantation. However, no significant association was found between the postulated risk factors and the incidence of NODAT. Conclusion: The incidence of NODAT was 10% throughout 6 months after transplantation. Correlations between sociodemographic characteristics, immunosuppressant regimens, episodes of rejection with the incidence of NODAT were found statistically insignificant.
first_indexed 2024-12-14T06:26:37Z
format Article
id doaj.art-e4f8520dfd754aa7a43f227f58c87e0f
institution Directory Open Access Journal
issn 2348-3334
2348-506X
language English
last_indexed 2024-12-14T06:26:37Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series CHRISMED Journal of Health and Research
spelling doaj.art-e4f8520dfd754aa7a43f227f58c87e0f2022-12-21T23:13:39ZengWolters Kluwer Medknow PublicationsCHRISMED Journal of Health and Research2348-33342348-506X2021-01-018211011610.4103/cjhr.cjhr_45_20Incidence of new-onset diabetes among sudanese renal transplant patients using different immunosuppressive regimens: A retrospective studyAlaa Mohammedazeem ElzainSafaa BadiBashir Alsiddig YousefHabab Khalid ElkheirBackground: New onset diabetes after renal transplant (NODAT) is a serious complication of therapy with immunosuppressive drugs. The aim of this study was to estimate the incidence of NODAT and its association with immunosuppressant regimens within 6 months of the administration. Methodology: A descriptive retrospective case finding hospital-based study, conducted in the department of nephrology at Ahmed Gasim Hospital from January to September 2017, on patients who underwent renal transplantation between June 2015 and June 2016. The data were collected using a structured checklist. The collected data were analyzed by the Statistical Package for Social Sciences (SPSS). Results: A total of 110 patients were included, the majority of studied patients were males (71.8%) and in the age group of 20–40 years (50.9%). The most commonly prescribed immunosuppressant regimen was regimen, which consists of methylprednisolone as induction therapy and tacrolimus + azathioprine + prednisolone as maintenance therapy. Regarding the adverse effects, 11 (10%) of them developed NODAT throughout 6 months after transplantation. However, no significant association was found between the postulated risk factors and the incidence of NODAT. Conclusion: The incidence of NODAT was 10% throughout 6 months after transplantation. Correlations between sociodemographic characteristics, immunosuppressant regimens, episodes of rejection with the incidence of NODAT were found statistically insignificant.http://www.cjhr.org/article.asp?issn=2348-3334;year=2021;volume=8;issue=2;spage=110;epage=116;aulast=Elzain immunosuppressive regimensincidencenew-onset diabetesrenal transplantation
spellingShingle Alaa Mohammedazeem Elzain
Safaa Badi
Bashir Alsiddig Yousef
Habab Khalid Elkheir
Incidence of new-onset diabetes among sudanese renal transplant patients using different immunosuppressive regimens: A retrospective study
CHRISMED Journal of Health and Research
immunosuppressive regimens
incidence
new-onset diabetes
renal transplantation
title Incidence of new-onset diabetes among sudanese renal transplant patients using different immunosuppressive regimens: A retrospective study
title_full Incidence of new-onset diabetes among sudanese renal transplant patients using different immunosuppressive regimens: A retrospective study
title_fullStr Incidence of new-onset diabetes among sudanese renal transplant patients using different immunosuppressive regimens: A retrospective study
title_full_unstemmed Incidence of new-onset diabetes among sudanese renal transplant patients using different immunosuppressive regimens: A retrospective study
title_short Incidence of new-onset diabetes among sudanese renal transplant patients using different immunosuppressive regimens: A retrospective study
title_sort incidence of new onset diabetes among sudanese renal transplant patients using different immunosuppressive regimens a retrospective study
topic immunosuppressive regimens
incidence
new-onset diabetes
renal transplantation
url http://www.cjhr.org/article.asp?issn=2348-3334;year=2021;volume=8;issue=2;spage=110;epage=116;aulast=Elzain
work_keys_str_mv AT alaamohammedazeemelzain incidenceofnewonsetdiabetesamongsudaneserenaltransplantpatientsusingdifferentimmunosuppressiveregimensaretrospectivestudy
AT safaabadi incidenceofnewonsetdiabetesamongsudaneserenaltransplantpatientsusingdifferentimmunosuppressiveregimensaretrospectivestudy
AT bashiralsiddigyousef incidenceofnewonsetdiabetesamongsudaneserenaltransplantpatientsusingdifferentimmunosuppressiveregimensaretrospectivestudy
AT hababkhalidelkheir incidenceofnewonsetdiabetesamongsudaneserenaltransplantpatientsusingdifferentimmunosuppressiveregimensaretrospectivestudy